Ads
related to: allermine tablet same as piriton treatment for diabetes- T1D Risk Factors
Take the Type 1 Risk Quiz to
Understand Your Risk for T1D
- What You Need to Know
Learn the Risk Factors of T1D.
Take the Type 1 Risk Quiz
- Screen Early for T1D
Learn the Importance of
Screening Early
- Doctor Discussion Guide
Download the Doctor Discussion
Guide for More on Screening & T1D.
- Screen Early
Talk to Your Doctor About
Screening Early for T1D
- Take the 1 Pledge
Take the Pledge to Screen
for Type 1 Diabetes. Learn More.
- T1D Risk Factors
Search results
Results From The WOW.Com Content Network
Chlorphenamine (CP, CPM), also known as chlorpheniramine, is an antihistamine used to treat the symptoms of allergic conditions such as allergic rhinitis (hay fever). [2] It is taken orally (by mouth). [2]
Glimepiride is an antidiabetic medication within the sulfonylurea class, primarily prescribed for the management of type 2 diabetes. [1] [2] It is regarded as a second-line option compared to metformin, due to metformin's well-established safety and efficacy. [1]
Type 2 diabetes is the most common type of diabetes. Treatments include agents that (1) increase the amount of insulin secreted by the pancreas, (2) increase the sensitivity of target organs to insulin, (3) decrease the rate at which glucose is absorbed from the gastrointestinal tract, and (4) increase the loss of glucose through urination.
Novo Nordisk is the maker of Ozempic, which is approved for type 2 diabetes treatment and reduced risk of cardiovascular events. The risk of gastrointestinal problems — including nausea, ...
The main goal of diabetes management is to keep blood glucose (BG) levels as normal as possible. [1] If diabetes is not well controlled, further challenges to health may occur. [1] People with diabetes can measure blood sugar by various methods, such as with a BG meter or a continuous glucose monitor, which monitors over several days. [2]
The study found an overall 1.4 fold increase in risk of cardiovascular ischemic events relative to the control arms. The results were heterogenous, with clear evidence of increased risk relative to placebo but not relative to other diabetes treatments and higher risk associated with combinations of rosiglitazone with insulin or metformin. [28]